Mannitolo Monico

Mannitol, the active ingredient in Mannitolo Monico, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to lower intracranial pressure, manage acute renal failure, promote diuresis in oliguric patients, and reduce intraocular pressure, especially in critical care settings.

GNH USA supplies Mannitolo Monico as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide, including emergency departments and intensive care units, with a focus on reliable cold‑chain logistics and regulatory compliance.

Mannitol is an osmotic diuretic used in several clinical situations that involve fluid shift and pressure reduction. - Intracranial hypertension: lowers intracranial pressure by drawing fluid from brain tissue into the vascular compartment. - Acute renal failure with oliguria: promotes diuresis to improve urine output and renal clearance. - Intraocular hypertension: reduces intraocular pressure in glaucoma or ocular surgery. - Cerebral edema: assists in managing brain swelling after trauma or stroke.

Mannitol may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Nausea - Vomiting - Flushing - Thirst - Electrolyte imbalance (e.g., hyponatremia)

Serious or Rare Side Effects: - Pulmonary edema - Severe electrolyte disturbances (e.g., hyperkalemia) - Worsening renal failure - Anaphylactoid reactions - Hemolysis in G6PD‑deficient patients - Cardiac arrhythmias

When using Mannitol, clinicians should observe several safety measures to minimize risks. - Monitor serum electrolytes: check sodium, potassium and osmolality regularly. - Assess renal function: evaluate creatinine and urine output before and during therapy. - Avoid in severe dehydration: ensure adequate intravascular volume. - Use caution in heart failure or pulmonary edema: adjust infusion rate. - Adjust infusion rate in patients at risk of hypotension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Mannitol can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Loop diuretics: may enhance diuresis and electrolyte loss. - Nephrotoxic antibiotics (e.g., aminoglycosides): increase risk of renal toxicity. - Insulin: can potentiate hypoglycemia due to electrolyte shifts.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect. - Corticosteroids: may affect fluid balance. - Vasopressors: can counteract volume expansion.